SciELO - Scientific Electronic Library Online

 
vol.56 issue3An Alternative Approach for Acetylation of Amine Terminated Polyamidoamine (PAMAM) DendrimerProtein and Peptide in Drug Targeting and its Therapeutic Approach author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Ars Pharmaceutica (Internet)

On-line version ISSN 2340-9894

Abstract

GOMEZ DE RUEDA, Félix  and  TENA SEMPERE, Mª Eugenia. Clinical-epidemiological characteristics of inpatients in antibiotic treatment of restricted use in a second level hospital: analysis of prescription. Ars Pharm [online]. 2015, vol.56, n.3, pp.161-164. ISSN 2340-9894.  http://dx.doi.org/10.4321/S2340-98942015000300005.

Introduction: The improper use of restricted antibiotics (ATBr) in the hospital environment, currently constitute a major health problem. Their indiscriminate use and the absence of oversight by specialists in infectious diseases, are contributing to an accelerated selection of resistant strains, which translates into an increasingly smaller therapeutic arsenal. Objective: To analyze the right or wrong indication of restricted antibiotics in our hospital, according to the primary diagnosis. Material and methods: Observational and descriptive study of a series of 126 consecutive cases analyzed over six months, in which we reviewed both stories clinics as requests for restricted antibiotics. Results: The 61.11% of patients who are prescribed an ATBr had been treated prior and a 19.84% the ATBr were prescribed home. The 73% remaining prescriptions were inadequate or incomplete.

Keywords : restricted antibiotic; bacterial resistance; hospital setting.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License